Wednesday, July 8, 2026

pharma · Mild/non-serious osteoarthritis (OA) of the knee.

Haleon - Gebro

Haleon - Gebro clinical programs — 2 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.

Fieberbrunn, AU HQ
179 Employees
TGA registrant Type
Company details
Status
Public
HQ
Fieberbrunn, AU
Employees
179
Programs
3
Drugs
9
Patents
0
Intelligence · Clinical Programs

Haleon - Gebro projects

2 ClinicalTrials.gov programs sponsored by Haleon - Gebro.

Haleon - Gebro has 2 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.

Clinical programs

  1. 300141

    HALEON AUSTRALIA PTY LTD

    Healthy volunteers, therapeutic indication not studied

    phase 1 other active

    1 trial
  2. 400314

    HALEON AUSTRALIA PTY LTD

    For the local, symptomatic treatment of pain in acute bruises, strains, or sprains due to blunt trauma, e.g., sports and accident injuries

    phase 1 other active

    1 trial

Frequently asked questions

How many clinical projects does Haleon - Gebro have?

2 published programs are linked to this sponsor in our ClinicalTrials.gov index.

Is this the complete company pipeline?

This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.